Pharmosa Biopharm Inc. (6875.TWO)
TWD 44.8
(-0.44%)
TWD 44.8
(-0.44%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 29.13 Million TWD | 113.68% |
| 2022 | -257.08 Million TWD | -3.98% |
| 2021 | -244.12 Million TWD | -45.59% |
| 2020 | -171.84 Million TWD | -44.76% |
| 2019 | -115.51 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -52.12 Million TWD | -12.3% |
| 2024 Q1 | -46.53 Million TWD | 43.6% |
| 2023 Q3 | 238.89 Million TWD | 485.36% |
| 2023 FY | - TWD | 113.68% |
| 2023 Q4 | -82.18 Million TWD | -134.4% |
| 2023 Q2 | -61.99 Million TWD | -3.18% |
| 2023 Q1 | -60.07 Million TWD | -32.88% |
| 2022 Q4 | -45.21 Million TWD | 29.1% |
| 2022 Q3 | -63.77 Million TWD | 0.0% |
| 2022 FY | - TWD | -3.98% |
| 2021 FY | - TWD | -45.59% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sagittarius Life Science Corp | -44.73 Million TWD | 165.111% |
| Neith Corporation | -33.61 Million TWD | 186.671% |
| TaiRx, Inc. | -208.64 Million TWD | 113.961% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 125.755% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 188.257% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 153.046% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 92.599% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 140.394% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 120.272% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 128.114% |
| Visgeneer Inc. | 973 Thousand TWD | -2893.834% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 96.889% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 70.822% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 1777.029% |
| Enimmune corporation | -228.96 Million TWD | 112.723% |
| EirGenix Inc. | -664.4 Million TWD | 104.384% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 60.584% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 57.87% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 16.384% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 210.76% |
| RBC Bioscience Corporation | 36.54 Million TWD | 20.294% |
| BiOptic Inc. | 65.03 Million TWD | 55.211% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 162.992% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 93.281% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 108.581% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 102.939% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 146.727% |
| Level Biotechnology Inc. | 98.7 Million TWD | 70.488% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 215.444% |
| GlycoNex Incorporation | -126.82 Million TWD | 122.968% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -33.563% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 264.335% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 102.719% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 104.268% |
| VBI | -6.97 Million TWD | 517.814% |
| CHO Pharma, Inc. | -277.73 Million TWD | 110.489% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 136.38% |
| NaviFUS Corp. | -55.79 Million TWD | 152.209% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 275.503% |
| Sinew Pharma Inc. | -163.63 Million TWD | 117.802% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 147.366% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 84.86% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 112.851% |
| AP Biosciences Inc | -325.51 Million TWD | 108.949% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 102.789% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 181.264% |
| Intech Biopharm Corporation | -219.58 Million TWD | 113.266% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 104.32% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 164.804% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 118.109% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 95.556% |
| TCI GENE Inc. | 25.98 Million TWD | -12.12% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 126.329% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 110.265% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 119.956% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -110.325% |
| PharmaEngine, Inc. | 347.3 Million TWD | 91.613% |
| Savior Lifetec Corporation | 219.6 Million TWD | 86.735% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 83.087% |
| OBI Pharma, Inc. | -855.08 Million TWD | 103.407% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 131.47% |
| Acepodia, Inc. | -764.51 Million TWD | 103.81% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 106.331% |